Parametrica Management Ltd Takes Position in Avantor, Inc. (NYSE:AVTR)

Parametrica Management Ltd purchased a new stake in shares of Avantor, Inc. (NYSE:AVTR) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 8,334 shares of the company’s stock, valued at approximately $216,000.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Intech Investment Management LLC boosted its position in Avantor by 1.8% during the second quarter. Intech Investment Management LLC now owns 29,068 shares of the company’s stock valued at $616,000 after purchasing an additional 514 shares in the last quarter. Arizona State Retirement System boosted its position in Avantor by 0.3% during the second quarter. Arizona State Retirement System now owns 186,567 shares of the company’s stock valued at $3,955,000 after purchasing an additional 528 shares in the last quarter. Veracity Capital LLC boosted its position in Avantor by 1.0% during the third quarter. Veracity Capital LLC now owns 52,359 shares of the company’s stock valued at $1,355,000 after purchasing an additional 543 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in Avantor by 2.8% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 26,921 shares of the company’s stock worth $571,000 after acquiring an additional 733 shares in the last quarter. Finally, US Bancorp DE boosted its holdings in Avantor by 6.2% in the third quarter. US Bancorp DE now owns 12,615 shares of the company’s stock worth $326,000 after acquiring an additional 734 shares in the last quarter. Institutional investors own 95.08% of the company’s stock.

Avantor Stock Performance

NYSE:AVTR traded down $0.04 during trading hours on Wednesday, reaching $21.75. The company had a trading volume of 537,605 shares, compared to its average volume of 6,414,365. Avantor, Inc. has a 1-year low of $18.82 and a 1-year high of $28.00. The firm has a market cap of $14.80 billion, a PE ratio of 47.39, a price-to-earnings-growth ratio of 2.70 and a beta of 1.35. The business’s 50 day moving average price is $24.77 and its 200-day moving average price is $24.07. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06.

Analysts Set New Price Targets

Several brokerages have weighed in on AVTR. Robert W. Baird lowered their price target on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a report on Monday, October 28th. Morgan Stanley raised their price target on Avantor from $28.00 to $29.00 and gave the stock an “overweight” rating in a report on Monday, July 29th. Royal Bank of Canada reissued an “outperform” rating and issued a $34.00 price target on shares of Avantor in a report on Thursday, September 26th. Wells Fargo & Company lowered their price target on Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a report on Monday, October 28th. Finally, Stifel Nicolaus raised their price target on Avantor from $27.00 to $28.00 and gave the stock a “buy” rating in a report on Monday, July 29th. Three investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, Avantor has a consensus rating of “Moderate Buy” and a consensus price target of $27.57.

Insider Buying and Selling at Avantor

In other news, CAO Steven W. Eck sold 3,525 shares of the company’s stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the completion of the transaction, the chief accounting officer now directly owns 29,544 shares of the company’s stock, valued at $740,372.64. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. 1.30% of the stock is currently owned by corporate insiders.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.